• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助治疗对局部晚期胃癌患者身体成分的影响。

Impact of Neoadjuvant Treatment on Body Composition in Patients with Locally Advanced Gastric Cancer.

作者信息

Juez Luz Divina, Priego Pablo, Cuadrado Marta, Blázquez Luis A, Sánchez-Picot Silvia, Gil Pablo, Longo Federico, Galindo Julio, Fernández-Cebrián José María, Botella-Carretero José I

机构信息

Department of General and Digestive Surgery, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.

Instituto Ramón y Cajal de Investigación Sanitaria, IRyCIS, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.

出版信息

Cancers (Basel). 2024 Jun 29;16(13):2408. doi: 10.3390/cancers16132408.

DOI:10.3390/cancers16132408
PMID:39001470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11240361/
Abstract

Neoadjuvant chemotherapy (NT) followed by radical surgery is the standard treatment for locally advanced gastric cancer (GC). The incidence of sarcopenia in upper gastrointestinal tract malignancies is very high, and it may be increased after NT. This study aimed to evaluate the impact of NT on body composition. A retrospective study of patients with locally advanced GC undergoing gastrectomy who had received NT in a tertiary hospital between 2012 and 2019 was conducted. CT measured the skeletal muscle index, total psoas area, and visceral and subcutaneous adipose tissue before and after NT. Of the 180 gastrectomies for GC, 61 patients received NT. During NT, changes in body composition were observed with a decrease in the skeletal muscle mass index (SMMI -2.5%; < 0.001), and these changes were significantly greater in men (SMMI -10.55%). Before surgery, patients who received NT presented 15% more sarcopenia than those without NT ( = 0.048). In conclusion, patients with locally advanced gastric cancer who receive NT have significant changes in body composition during chemotherapy. These changes, which are at the expense of a loss of muscle mass, lead to an increased incidence of pre-surgical sarcopenia.

摘要

新辅助化疗(NT)后行根治性手术是局部晚期胃癌(GC)的标准治疗方法。上消化道恶性肿瘤患者中肌肉减少症的发生率非常高,NT治疗后该发生率可能会增加。本研究旨在评估NT对身体成分的影响。对2012年至2019年期间在一家三级医院接受NT治疗并行胃切除术的局部晚期GC患者进行了一项回顾性研究。通过CT测量NT前后的骨骼肌指数、腰大肌总面积以及内脏和皮下脂肪组织。在180例GC胃切除术中,61例患者接受了NT治疗。在NT治疗期间,观察到身体成分发生变化,骨骼肌质量指数下降(SMMI -2.5%;<0.001),男性的这些变化更为显著(SMMI -10.55%)。术前,接受NT治疗的患者肌肉减少症发生率比未接受NT治疗的患者高15%(=0.048)。总之,接受NT治疗的局部晚期胃癌患者在化疗期间身体成分发生显著变化。这些变化以肌肉量减少为代价,导致术前肌肉减少症发生率增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/2390216137e7/cancers-16-02408-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/c26a5a942d6f/cancers-16-02408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/ca7e6c2b08ae/cancers-16-02408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/2f4a10a9d3e6/cancers-16-02408-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/2390216137e7/cancers-16-02408-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/c26a5a942d6f/cancers-16-02408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/ca7e6c2b08ae/cancers-16-02408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/2f4a10a9d3e6/cancers-16-02408-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f24b/11240361/2390216137e7/cancers-16-02408-g004.jpg

相似文献

1
Impact of Neoadjuvant Treatment on Body Composition in Patients with Locally Advanced Gastric Cancer.新辅助治疗对局部晚期胃癌患者身体成分的影响。
Cancers (Basel). 2024 Jun 29;16(13):2408. doi: 10.3390/cancers16132408.
2
Impact of body composition on clinical outcomes in people with gastric cancer undergoing radical gastrectomy after neoadjuvant treatment.新辅助治疗后行根治性胃切除术的胃癌患者体成分与临床结局的关系。
Nutrition. 2021 May;85:111135. doi: 10.1016/j.nut.2020.111135. Epub 2021 Jan 5.
3
Marked loss of adipose tissue during neoadjuvant therapy as a predictor for poor prognosis in patients with gastric cancer: A retrospective cohort study.新辅助治疗期间明显的脂肪组织丢失可作为预测胃癌患者预后不良的指标:一项回顾性队列研究。
J Hum Nutr Diet. 2021 Jun;34(3):585-594. doi: 10.1111/jhn.12861. Epub 2021 Jan 25.
4
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer.体成分变化与胰腺癌新辅助治疗的关系。
JAMA Surg. 2018 Sep 1;153(9):809-815. doi: 10.1001/jamasurg.2018.0979.
5
Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international study.身体成分参数预测新辅助治疗后局部晚期胃癌的病理反应和结局:一项多中心国际研究。
Clin Nutr. 2021 Aug;40(8):4980-4987. doi: 10.1016/j.clnu.2021.06.021. Epub 2021 Jun 25.
6
Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.胃癌新辅助化疗期间骨骼肌量变化的临床影响:JCOG1002 的辅助研究。
World J Surg. 2024 Jan;48(1):163-174. doi: 10.1002/wjs.12041. Epub 2023 Dec 18.
7
Body composition change during neoadjuvant chemotherapy for breast cancer.乳腺癌新辅助化疗期间的身体成分变化
Front Oncol. 2022 Aug 26;12:941496. doi: 10.3389/fonc.2022.941496. eCollection 2022.
8
CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.肌少症和肌少症肥胖的CT身体成分:局部晚期食管腺癌患者术后并发症和生存的预测因素
Cancers (Basel). 2021 Jun 11;13(12):2921. doi: 10.3390/cancers13122921.
9
Visceral-to-subcutaneous fat ratio exhibits strongest association with early post-operative outcomes in patients undergoing surgery for advanced rectal cancer.内脏脂肪与皮下脂肪比率与接受先进直肠癌手术患者的术后早期结果具有最强相关性。
Int J Colorectal Dis. 2022 Aug;37(8):1893-1900. doi: 10.1007/s00384-022-04221-8. Epub 2022 Jul 28.
10
Preoperative computed tomography-determined sarcopenia is a reliable prognostic factor in patients with gastric cancer after radical gastrectomy: A sex-specific analysis.术前计算机断层扫描确定的肌肉减少症是胃癌根治术后患者的可靠预后因素:一项性别特异性分析。
Front Nutr. 2022 Oct 24;9:884586. doi: 10.3389/fnut.2022.884586. eCollection 2022.

引用本文的文献

1
Gastric Cancer Surgery Before and During the COVID-19 Pandemic in Turkey: A Multicenter Comparison of Prognostic Factors, Mortality, and Survival.土耳其 COVID-19 大流行之前及期间的胃癌手术:预后因素、死亡率和生存率的多中心比较
Medicina (Kaunas). 2025 Jul 24;61(8):1336. doi: 10.3390/medicina61081336.
2
Impact of Preoperative CT-Diagnosed Sarcopenic Obesity on Outcomes After Radical Cystectomy for Bladder Cancer.术前CT诊断的肌少症肥胖对膀胱癌根治性膀胱切除术后结局的影响。
Cancers (Basel). 2025 Aug 15;17(16):2669. doi: 10.3390/cancers17162669.
3
Postoperative Changes in Body Composition Predict Long-Term Prognosis in Patients with Gastric Cancer.

本文引用的文献

1
Impact of Sarcopenic Obesity on Long-Term Cancer Outcomes and Postoperative Complications After Gastrectomy for Gastric Cancer.肌肉减少性肥胖对胃癌根治术后长期癌症结局和术后并发症的影响。
J Gastrointest Surg. 2023 Jan;27(1):35-46. doi: 10.1007/s11605-022-05492-w. Epub 2022 Nov 2.
2
Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.基于氟尿嘧啶的不可切除胃癌患者一线姑息化疗中骨骼肌量的影响。
BMC Cancer. 2021 Nov 13;21(1):1219. doi: 10.1186/s12885-021-08953-8.
3
Prognostic aspects of lymphovascular invasion in localized gastric cancer: new insights into the radiomics and deep transfer learning from contrast-enhanced CT imaging.
胃癌患者术后身体成分变化预测长期预后
Cancers (Basel). 2025 Feb 21;17(5):738. doi: 10.3390/cancers17050738.
局部胃癌中淋巴管浸润和血管浸润的预后方面:从增强 CT 成像的放射组学和深度迁移学习中获得的新见解。
Abdom Radiol (NY). 2022 Feb;47(2):496-507. doi: 10.1007/s00261-021-03309-z. Epub 2021 Nov 11.
4
Risk factors associated with postoperative morbidity and mortality in D2 radical gastrectomy for gastric cancer.胃癌 D2 根治术后并发症和死亡率的相关风险因素。
Rev Gastroenterol Mex (Engl Ed). 2022 Apr-Jun;87(2):149-158. doi: 10.1016/j.rgmxen.2021.07.003. Epub 2021 Aug 4.
5
Impact of perioperative chemotherapy on postoperative morbidity after gastrectomy for gastric cancer.围手术期化疗对胃癌胃切除术后并发症的影响。
Cir Esp (Engl Ed). 2021 Aug-Sep;99(7):521-526. doi: 10.1016/j.cireng.2021.07.007.
6
Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study.胃癌患者术前FLOT治疗期间的身体成分变化:一项意大利队列研究的初步结果
Nutrients. 2021 Mar 16;13(3):960. doi: 10.3390/nu13030960.
7
Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long-term outcomes after gastrectomy.术前化疗导致进展期胃癌患者的腰肌耗竭对胃切除术后的长期预后有负面影响。
Asia Pac J Clin Oncol. 2022 Feb;18(1):61-69. doi: 10.1111/ajco.13514. Epub 2021 Feb 28.
8
Impact of body composition on clinical outcomes in people with gastric cancer undergoing radical gastrectomy after neoadjuvant treatment.新辅助治疗后行根治性胃切除术的胃癌患者体成分与临床结局的关系。
Nutrition. 2021 May;85:111135. doi: 10.1016/j.nut.2020.111135. Epub 2021 Jan 5.
9
Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro-oesophageal cancer.新辅助化疗治疗胃食管交界癌时骨骼肌质量变化对术后并发症的影响。
BJS Open. 2020 Oct;4(5):847-854. doi: 10.1002/bjs5.50331. Epub 2020 Aug 25.
10
Japanese gastric cancer treatment guidelines 2018 (5th edition).《日本胃癌治疗指南2018(第5版)》
Gastric Cancer. 2021 Jan;24(1):1-21. doi: 10.1007/s10120-020-01042-y. Epub 2020 Feb 14.